UCLA spin-out Tribogenics landed $2.5 million from a network of angel investors and Flywheel Ventures for the commercialization of its next-generation x-ray technology.
Tribogenics’ technology, developed at UCLA by Carlos Camara, enables low-cost X-ray sources for scientific instruments, security screening and medical devices.